Table 2.
Study | Health-related costs | Non-health-related costs |
---|---|---|
Aziz et al. [19] | Medical examination and evaluation (i.e. cost of doctor and other diagnostics) | NR |
Chay et al. [25] | Medical costs, assistive technologies, carer cost | Expected productivity loss |
Frick et al. [20] | Inpatient hospital admissions, inpatient hospital days, emergency department visits, outpatient physician visits, prescription drug fills | NR |
Galvin et al. [6] | Primary/secondary care, diagnostic tests, pharmaceuticals, vitamins and supplements, medical research | Wellbeing costs, productivity loss, deadweight losses, informal care costs |
Gong et al. [7] | Primary/secondary care, diagnostic tests, pharmaceuticals, vitamins and supplements | Wellbeing costs, productivity loss, deadweight losses, informal care costs |
Kessel et al. [23] | Primary care, outpatient services, inpatient admissions, prescription medication | NR |
Schofield et al. [22] | Direct healthcare costs such as use of health products such as pharmaceuticals (unspecified) | Productivity loss, government service and NDIS costs, informal care costs |
Dong et al. [21] | Inpatient admissions, outpatient visits, ED visits, pharmacy prescriptions | NR |
Watanabe et al. [24] | Healthcare services, paid care, medications and supplements, vision aids | Productivity loss, financial aid received |
Abbreviations: NDIS, national disability insurance scheme; NR, not reported